March 27th, 2010
Podcast 80: Bisphosphonates and atypical hip fractures — how large is the risk?
We talk with three of the academic authors of a New England Journal of Medicine study that pooled data from a few studies in an attempt to examine the possible link between use of bisphosphonates and femoral-shaft fractures. Interview-related links: Physician’s First Watch coverage NEJM paper NEJM editorial FDA statement News-related links: Aspirin ineffective in preventing miscarriage BNP-guided […]
March 19th, 2010
Podcast 79: Prostate cancer, patients’ consultations, and the treatments they receive
Patients who consult urologists only are more likely to get radical prostatectomy, and those who consult both urologists and radiation oncologists are more likely to get radiation. Those who see internists are more likely to receive watchful waiting. What are all these facts trying to tell us? Our conversation is with the principal authors of a […]
March 12th, 2010
Podcast 78: Just what are “comparative effectiveness” studies anyway?
This week, a conversation with Michael Hochman on his examination of what the major general journals publish in the way of comparative effectiveness studies. He talks about what they are and how to think about that reprint that the drug rep has just dropped off for you. Reach us at 617-440-4374, or write to jelia@jwatch.org. This week’s […]
March 5th, 2010
Podcast 77: We revisit a conversation on treating community-acquired pneumonia according to the guidelines (and we’ve got current news).
Our attempts to get an interview with a researcher were unavailing, so we’ve gone to plan B and repeat a useful look at treating community-acquired pneumonia according to guideline recommendations. Please leave comments and complaints at jelia@jwatch.org. You can call and voice these at 1-617-440-4374. Interview-related links: Community-Acquired Pneumonia: Guideline-Compliant Treatment Is Better IDSA/ATS guidelines News-related links: Evaluating long-term […]
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
